MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,931 | -99.9% | 329,146 | -24.0% | 0.00% | -33.3% |
| Q3 2022 | $13,647,000 | +4.6% | 432,828 | +0.9% | 0.01% | +20.0% |
| Q2 2022 | $13,051,000 | +109.2% | 429,040 | +72.9% | 0.01% | +150.0% |
| Q1 2022 | $6,240,000 | -20.3% | 248,089 | -35.3% | 0.00% | 0.0% |
| Q4 2021 | $7,827,000 | -28.4% | 383,658 | -32.5% | 0.00% | -33.3% |
| Q3 2021 | $10,927,000 | -27.5% | 567,969 | -16.5% | 0.00% | -25.0% |
| Q2 2021 | $15,082,000 | -9.0% | 679,971 | +7.7% | 0.00% | -20.0% |
| Q1 2021 | $16,569,000 | +38.5% | 631,193 | -1.4% | 0.01% | +25.0% |
| Q4 2020 | $11,967,000 | -15.8% | 640,327 | -23.5% | 0.00% | -20.0% |
| Q3 2020 | $14,217,000 | -36.9% | 837,281 | -13.4% | 0.01% | -44.4% |
| Q2 2020 | $22,516,000 | +250.4% | 966,788 | +26.4% | 0.01% | +200.0% |
| Q1 2020 | $6,425,000 | +26.4% | 764,903 | +47.0% | 0.00% | +50.0% |
| Q4 2019 | $5,084,000 | +22.2% | 520,425 | +18.7% | 0.00% | 0.0% |
| Q3 2019 | $4,161,000 | +28.0% | 438,509 | +60.2% | 0.00% | +100.0% |
| Q2 2019 | $3,251,000 | – | 273,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brown Capital Management | 5,709,876 | $117,681,000 | 1.95% |
| Piermont Capital Management Inc. | 118,909 | $2,451,000 | 0.78% |
| ZEVIN ASSET MANAGEMENT LLC | 120,325 | $2,480,000 | 0.70% |
| CONNORS INVESTOR SERVICES INC | 151,945 | $3,132,000 | 0.62% |
| Randolph Co Inc | 107,200 | $2,209,000 | 0.49% |
| NAPLES GLOBAL ADVISORS, LLC | 51,172 | $1,055,000 | 0.44% |
| Boston Trust Walden Corp | 1,098,713 | $22,645,000 | 0.39% |
| MCKINLEY CAPITAL MANAGEMENT LLC | 348,934 | $7,192,000 | 0.35% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 248,900 | $5,130,000 | 0.30% |
| Cardinal Capital Management | 32,137 | $662,000 | 0.28% |